Matti Ristola Selected Research

Matti Ristola Research Topics

6	Lipodystrophy 07/2011 - 11/2002
3	HIV Infections (HIV Infection) 01/2015 - 05/2009
2	Infections 01/2011 - 05/2009
2	Inflammation (Inflammations) 06/2010 - 07/2008
2	Insulin Resistance 06/2003 - 11/2002
1	Coinfection 03/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2015
1	Atherosclerosis 06/2010
1	Diarrhea 07/2004
1	Type 2 Diabetes Mellitus (MODY) 06/2003
1	Body Weight (Weight, Body) 06/2003
1	Atrophy 06/2003

2	Insulin (Novolin)FDA Link 06/2003 - 11/2002
1	Drinking WaterIBA 01/2015
1	Immunoglobulin G (IgG)IBA 01/2011
1	Immunoglobulin M (IgM)IBA 01/2011
1	Immunoglobulins (Immunoglobulin)IBA 01/2011
1	C-Reactive ProteinIBA 06/2010
1	fibrin fragment D (D-dimer)IBA 06/2010
1	InterleukinsIBA 06/2010
1	RNA (Ribonucleic Acid)IBA 06/2010
1	Biomarkers (Surrogate Marker)IBA 06/2010
1	Interleukin-6 (Interleukin 6)IBA 06/2010
1	Cystatin CIBA 06/2010
1	NucleosidesIBA 05/2009
1	Zidovudine (Retrovir)FDA LinkGeneric 05/2009
1	Stavudine (Zerit)FDA LinkGeneric 05/2009
1	Reverse Transcriptase InhibitorsIBA 05/2009
1	Lamivudine (Epivir)FDA Link 05/2009
1	Ritonavir (Norvir)FDA Link 05/2009
1	CD11b AntigenIBA 07/2008
1	Hormones (Hormone)IBA 07/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2008
1	ChemokinesIBA 07/2008
1	MucinsIBA 07/2008
1	Metalloproteases (Metalloproteinases)IBA 07/2008
1	DisintegrinsIBA 07/2008
1	CC ChemokinesIBA 07/2008
1	LigandsIBA 07/2008
1	Epidermal Growth Factor (EGF)IBA 07/2008
1	LeptinIBA 06/2003
1	ThiazolidinedionesIBA 06/2003
1	Rosiglitazone (Avandia)FDA Link 06/2003

7	Therapeutics 03/2019 - 11/2002
5	Highly Active Antiretroviral Therapy (HAART) 07/2011 - 11/2002